Pyrimidines and CNS regulation: Changes in the levels of pyrimidines may lead to abnormal neurological activity
- 31 March 1996
- journal article
- other
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 17 (3) , 106
- https://doi.org/10.1016/0165-6147(96)20001-x
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Diagnostic analysis, clinical importance and molecular basis of dihydropyrimidine dehydrogenase deficiencyTrends in Pharmacological Sciences, 1995
- Evidence from desensitization studies for distinct receptors for ATP and UTP on the rat superior cervical ganglionBritish Journal of Pharmacology, 1994
- Inhibition of d-3-aminoisobutyrate-pyruvate aminotransferase by 5-fluorouracil and α-fluoro-β-alanineBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1992
- Disturbances of Cerebral Purine and Pyrimidine Metabolism in Young Children with Chronic Renal FailureNephron, 1991
- Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity.Journal of Clinical Investigation, 1988
- Reduced hippocampal field potentials during administration of fluoropyrimidinesin vitroActa Neurologica Scandinavica, 1987